Received Jul 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 3397T | — |
Havrix expired dose administration; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 3-year-old female patient who received HAV (Havrix) (batch number 3397T, expiry date 30-NOV-2023) for prophylaxis. On 28-FEB-2025, the patient received Havrix. On 28-FEB-2025, an unknown time after receiving Havrix, the patient experienced expired vaccine used (Verbatim: Havrix expired dose administration). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 10-JUL-2025 A health care provider wanted to know if a dose of Havrix (lot 3397T) was expired when it was administered on 28 February 2025. The agent confirmed that it expired on 30th November 2023, which led to expired vaccine used and offered to give the information of the recommendations in this case, but she mentioned that only wanted to receive it via email. The presentation given was pediatric, thus the adverse event it's only for the expired dose administration. The health care professional mentioned that the vaccine could have been given in the facility.